Myelodysplastic Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
Conditions: Myelodysplastic Syndromes; Ferroptosis Intervention: Biological: Biological sampling Sponsor: University Hospital, Bordeaux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials

The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
Condition: Lower Risk MDS Per IPSS-R Intervention: Drug: Luspatercept Sponsors: Institute of Hematology & Blood Diseases Hospital; Beijing Health Alliance Charitable Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials

Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes Interventions: Drug: KPT-8602; Drug: Inqovi Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2023 Category: Research Source Type: clinical trials

Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome
Conditions: Acute Leukemia; Myelodysplastic Syndromes Intervention: Sponsor: Peking University People's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials